Rapidly Expanded EBV-Specific T Cells for the Treatment of Refractory EBV Reactivation and EBV-Related Lymphoproliferative Disorders - Top-Institutions - MDSpire

Rapidly Expanded EBV-Specific T Cells for the Treatment of Refractory EBV Reactivation and EBV-Related Lymphoproliferative Disorders

  • By

  • Lorne Schweitzer

  • Stéphanie Thiant

  • Cynthia Thérien

  • Martin Giroux

  • Sylvie Lachance

  • Isabelle Fleury

  • Julie Orio

  • Cédric Carli

  • Gabrielle Boudreau

  • Julien Patenaude

  • Camille Tremblay-Laganière

  • Lynne Senécal

  • Simon F Dufresne

  • Luigina Mollica

  • Suzon Collette

  • Guy Sauvageau

  • Thomas Kiss

  • Sandra Cohen

  • Léa Bernard

  • Nadia Bambace

  • Olivier Veilleux

  • Imran Ahmad

  • Jean Roy

  • Lambert Busque

  • Michel Duval

  • Henrique Bittencourt

  • Pierre Teira

  • Caroline Lamarche

  • Denis-Claude Roy

  • Jean-Sébastien Delisle

  • January 20, 2026

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    Fred Hutchinson Cancer Center
    Fred Hutchinson Cancer Center

    Seattle, WA

    Key Differentiators

    • Hematology/Oncology
    • Cellular Therapy
    • Transplant Immunology

  • #2

    National Cancer Institute (NCI), NIH
    National Cancer Institute (NCI), NIH

    Bethesda, MD

    Key Differentiators

    • Cancer Immunotherapy
    • Virology
    • Hematology/Oncology

  • #3

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Hematology/Oncology
    • Cellular Therapy
    • Transplantation

  • #4

    University of Pennsylvania (Perelman School of Medicine)
    University of Pennsylvania (Perelman School of Medicine)

    Philadelphia, PA

    Key Differentiators

    • Cellular Immunotherapy
    • Hematology/Oncology
    • Transplant Medicine

  • #5

    St. Jude Children’s Research Hospital
    St. Jude Children’s Research Hospital

    Memphis, TN

    Key Differentiators

    • Pediatric Hematology/Oncology
    • Cellular Therapy
    • Immunotherapy

Original Source(s)

Rapidly Expanded EBV-Specific T Cells for the Treatment of Refractory EBV Reactivation and EBV-Related Lymphoproliferative Disorders

  • by Lorne Schweitzer, Stéphanie Thiant, Cynthia Thérien, Martin Giroux, Sylvie Lachance, Isabelle Fleury, Julie Orio, Cédric Carli, Gabrielle Boudreau, Julien Patenaude, Camille Tremblay-Laganière, Lynne Senécal, Simon F Dufresne, Luigina Mollica, Suzon Collette, Guy Sauvageau, Thomas Kiss, Sandra Cohen, Léa Bernard, Nadia Bambace, Olivier Veilleux, Imran Ahmad, Jean Roy, Lambert Busque, Michel Duval, Henrique Bittencourt, Pierre Teira, Caroline Lamarche, Denis-Claude Roy, Jean-Sébastien Delisle

  • January 20, 2026

Related Content

Efficacy of a novel device for cryoprevention of oral mucositis: a randomized, blinded, multicenter, parallel group, phase 3 trial

Refining CAR-NK Design

Preclinical findings suggest that receptor design and timed kinase inhibition could help strengthen next-generation cell therapies.

  • March 4, 2026

  • 2 min
Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022